TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April

Bulletin Express

04/27

Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.

In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.

The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1184590339"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1184590339\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1184590339?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-27 17:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1184590339","market":"us","top_or_hot":-1,"title":"TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April","media":"Bulletin Express","content":"<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.</p>\n<p>In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTONGRENTANGCM Highlights Publication of Tong Ren Tang Technologies’ Q1 2026 Unaudited Results; Parent Firm to Disclose Figures by 30 April\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-04-27 17:43</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.</p>\n<p>In addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.</p>\n<p>The board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03613","symbol_name":"同仁堂國藥","start_time":0,"source_url":"","article_id":"1184590339","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1184590339","pubTimestamp":1777283036,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03613":"同仁堂国药"},"translate_title":"同仁堂CM重点公布同仁堂科技2026年第一季度未经审计业绩；母公司将于4月30日前披露数据","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03613":1},"content_text":"Beijing Tong Ren Tang Chinese Medicine Company Limited (TONGRENTANGCM) informed the market that its controlling shareholder, Tong Ren Tang Technologies Co. Ltd., has released unaudited financial information for the three months ended 31 March 2026 on the Hong Kong Stock Exchange’s website. Investors seeking detailed figures can access the full announcement under stock code 1666 at www.hkexnews.hk.\nIn addition, Beijing Tong Ren Tang Company Limited, the controlling shareholder of Tong Ren Tang Technologies, will publish its own unaudited first-quarter 2026 results on the Shanghai Stock Exchange on or before 30 April 2026.\nThe board advised shareholders and potential investors to exercise caution when dealing in TONGRENTANGCM securities. The statement was authorised by Chairman Yan Han and released in Hong Kong on 27 April 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}